Literature DB >> 35836081

Bioluminescence-Optogenetics: A Practical Guide.

Matthew A Stern1, Henry Skelton1, Alejandra M Fernandez1, Claire-Anne N Gutekunst1, Ken Berglund2, Robert E Gross1.   

Abstract

Manipulation of neural activity in genetically predefined populations of neurons through genetic techniques is an essential tool in the field of neuroscience as well as a potential avenue in treating a vast assortment of neurological and psychiatric diseases. Here, we describe an emerging methodology of molecular neuromodulation termed bioluminescence-optogenetics (BL-OG) where BL is harnessed to activate bacterial light-driven channels and pumps expressed in neurons to control their activity. BL-OG is realized through opsin-luciferase fusion proteins called luminopsins (LMOs). In this chapter, we will provide a practical guide for applying BL-OG and LMOs in vitro using a cell line and primary cells in culture. In the following chapter, we will turn our focus towards BL-OG applications in ex vivo and in vivo rodent models of the nervous system.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Bioluminescence (BL); Channelrhodopsin; Chemogenetics; Coelenterazine; Halorhodopsin; Luciferase; Luciferin; Luminopsins (LMOs); Optogenetics (OG); Step-function opsin (SFO)

Mesh:

Substances:

Year:  2022        PMID: 35836081     DOI: 10.1007/978-1-0716-2473-9_26

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  11 in total

1.  Luminopsins integrate opto- and chemogenetics by using physical and biological light sources for opsin activation.

Authors:  Ken Berglund; Kara Clissold; Haofang E Li; Lei Wen; Sung Young Park; Jan Gleixner; Marguerita E Klein; Dongye Lu; Joseph W Barter; Mark A Rossi; George J Augustine; Henry H Yin; Ute Hochgeschwender
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-05       Impact factor: 11.205

2.  An optical neural interface: in vivo control of rodent motor cortex with integrated fiberoptic and optogenetic technology.

Authors:  Alexander M Aravanis; Li-Ping Wang; Feng Zhang; Leslie A Meltzer; Murtaza Z Mogri; M Bret Schneider; Karl Deisseroth
Journal:  J Neural Eng       Date:  2007-05-31       Impact factor: 5.379

3.  Bi-stable neural state switches.

Authors:  André Berndt; Ofer Yizhar; Lisa A Gunaydin; Peter Hegemann; Karl Deisseroth
Journal:  Nat Neurosci       Date:  2008-12-08       Impact factor: 24.884

4.  Optogenetics in neural systems.

Authors:  Ofer Yizhar; Lief E Fenno; Thomas J Davidson; Murtaza Mogri; Karl Deisseroth
Journal:  Neuron       Date:  2011-07-14       Impact factor: 17.173

Review 5.  Chemogenetic tools to interrogate brain functions.

Authors:  Scott M Sternson; Bryan L Roth
Journal:  Annu Rev Neurosci       Date:  2014-06-16       Impact factor: 12.449

6.  Defining parameters of specificity for bioluminescent optogenetic activation of neurons using in vitro multi electrode arrays (MEA).

Authors:  Mansi Prakash; William E Medendorp; Ute Hochgeschwender
Journal:  J Neurosci Res       Date:  2018-08-28       Impact factor: 4.164

7.  Step-function luminopsins for bimodal prolonged neuromodulation.

Authors:  Ken Berglund; Alejandra M Fernandez; Claire-Anne N Gutekunst; Ute Hochgeschwender; Robert E Gross
Journal:  J Neurosci Res       Date:  2019-04-07       Impact factor: 4.164

8.  Novel luciferase-opsin combinations for improved luminopsins.

Authors:  Sung Young Park; Sang-Ho Song; Brandon Palmateer; Akash Pal; Eric D Petersen; Gabrielle P Shall; Ryan M Welchko; Keiji Ibata; Atsushi Miyawaki; George J Augustine; Ute Hochgeschwender
Journal:  J Neurosci Res       Date:  2017-09-01       Impact factor: 4.164

9.  Monitoring neural activity with bioluminescence during natural behavior.

Authors:  Eva A Naumann; Adam R Kampff; David A Prober; Alexander F Schier; Florian Engert
Journal:  Nat Neurosci       Date:  2010-03-21       Impact factor: 24.884

10.  Light-emitting channelrhodopsins for combined optogenetic and chemical-genetic control of neurons.

Authors:  Ken Berglund; Elisabeth Birkner; George J Augustine; Ute Hochgeschwender
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.